AGMB
Price
$14.28
Change
+$0.26 (+1.85%)
Updated
Aug 26 closing price
Capitalization
704.25M
6 days until earnings call
Intraday BUY SELL Signals
CDIO
Price
$1.93
Change
+$0.02 (+1.05%)
Updated
Aug 26 closing price
Capitalization
5.71M
Intraday BUY SELL Signals
Interact to see
Advertisement

AGMB vs CDIO

AGMB vs CDIO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AGMB vs. CDIO commentary
Aug 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGMB is a Buy and CDIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2026
Stock price -- (AGMB: $14.28 vs. CDIO: $1.93)
Brand notoriety: AGMB and CDIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGMB: 223% vs. CDIO: 82%
Market capitalization -- AGMB: $704.25M vs. CDIO: $5.71M
AGMB [@Biotechnology] is valued at $704.25M. CDIO’s [@Biotechnology] market capitalization is $5.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.72B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGMB’s FA Score shows that 1 FA rating(s) are green whileCDIO’s FA Score has 0 green FA rating(s).

  • AGMB’s FA Score: 1 green, 4 red.
  • CDIO’s FA Score: 0 green, 5 red.
According to our system of comparison, AGMB is a better buy in the long-term than CDIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGMB’s TA Score shows that 5 TA indicator(s) are bullish while CDIO’s TA Score has 5 bullish TA indicator(s).

  • AGMB’s TA Score: 5 bullish, 3 bearish.
  • CDIO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AGMB is a better buy in the short-term than CDIO.

Price Growth

AGMB (@Biotechnology) experienced а +3.85% price change this week, while CDIO (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.14%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was +2942.87%.

Reported Earning Dates

AGMB is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (-0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGMB($704M) has a higher market cap than CDIO($5.71M).
AGMBCDIOAGMB / CDIO
Capitalization704M5.71M12,325%
EBITDAN/A-6.27M-
Gain YTDN/A-28.782-
P/E RatioN/AN/A-
RevenueN/A16.6K-
Total CashN/A7.08M-
Total DebtN/A533K-
TECHNICAL ANALYSIS
Technical Analysis
AGMBCDIO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
33%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 9 days ago
90%
Bullish Trend 7 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
View a ticker or compare two or three
Interact to see
Advertisement
AGMB
Daily Signal:
Gain/Loss:
CDIO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSTUX29.60N/A
N/A
Invesco Dividend Income Investor
OIERX29.32N/A
N/A
JPMorgan Equity Income R5
NCIGX39.90N/A
N/A
Nuveen International Value C
PJEZX18.66N/A
N/A
PGIM US Real Estate Z
LSVGX21.69N/A
N/A
LSV Global Value Institutional

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with OGEN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
+1.05%
OGEN - CDIO
37%
Loosely correlated
+1.90%
KRRO - CDIO
35%
Loosely correlated
-0.36%
FTH - CDIO
34%
Loosely correlated
-4.49%
ACOG - CDIO
32%
Poorly correlated
-3.49%
IMMP - CDIO
32%
Poorly correlated
-2.46%
More